These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
475 related articles for article (PubMed ID: 26604064)
1. A phase II study of neoadjuvant chemotherapy with S-1 and cisplatin for stage III gastric cancer: KUGC03. Okabe H; Hata H; Ueda S; Zaima M; Tokuka A; Yoshimura T; Ota S; Kinjo Y; Yoshimura K; Sakai Y; J Surg Oncol; 2016 Jan; 113(1):36-41. PubMed ID: 26604064 [TBL] [Abstract][Full Text] [Related]
2. Neoadjuvant chemotherapy with S-1 and cisplatin followed by D2 gastrectomy with para-aortic lymph node dissection for gastric cancer with extensive lymph node metastasis. Tsuburaya A; Mizusawa J; Tanaka Y; Fukushima N; Nashimoto A; Sasako M; Br J Surg; 2014 May; 101(6):653-60. PubMed ID: 24668391 [TBL] [Abstract][Full Text] [Related]
3. Impact of S-1 plus Cisplatin Neoadjuvant Chemotherapy on Scirrhous Gastric Cancer. Kunisaki C; Makino H; Kimura J; Takagawa R; Kanazawa A; Ota M; Kosaka T; Ono HA; Akiyama H; Endo I Oncology; 2015; 88(5):281-8. PubMed ID: 25591954 [TBL] [Abstract][Full Text] [Related]
4. Phase II study of preoperative chemotherapy with S-1 and cisplatin followed by gastrectomy for clinically resectable type 4 and large type 3 gastric cancers (JCOG0210). Iwasaki Y; Sasako M; Yamamoto S; Nakamura K; Sano T; Katai H; Tsujinaka T; Nashimoto A; Fukushima N; Tsuburaya A; J Surg Oncol; 2013 Jun; 107(7):741-5. PubMed ID: 23400787 [TBL] [Abstract][Full Text] [Related]
5. Phase II trial of preoperative S-1 plus cisplatin followed by surgery for initially unresectable locally advanced gastric cancer. Inoue K; Nakane Y; Kogire M; Fujitani K; Kimura Y; Imamura H; Tamura S; Okano S; Kwon AH; Kurokawa Y; Shimokawa T; Takiuchi H; Tsujinaka T; Furukawa H Eur J Surg Oncol; 2012 Feb; 38(2):143-9. PubMed ID: 22154885 [TBL] [Abstract][Full Text] [Related]
6. A phase II study of neoadjuvant chemotherapy with docetaxel, cisplatin, and S-1, followed by gastrectomy with D2 lymph node dissection for high-risk advanced gastric cancer: results of the KDOG1001 trial. Hosoda K; Azuma M; Katada C; Moriya H; Mieno H; Ishido K; Ema A; Ushiku H; Wada T; Washio M; Watanabe A; Higuchi K; Tanabe S; Koizumi W; Watanabe M; Yamashita K Gastric Cancer; 2019 May; 22(3):598-606. PubMed ID: 30284080 [TBL] [Abstract][Full Text] [Related]
7. A phase II study of neoadjuvant combination chemotherapy with docetaxel, cisplatin, and S-1 for locally advanced resectable gastric cancer: nucleotide excision repair (NER) as potential chemoresistance marker. Hirakawa M; Sato Y; Ohnuma H; Takayama T; Sagawa T; Nobuoka T; Harada K; Miyamoto H; Sato Y; Takahashi Y; Katsuki S; Hirayama M; Takahashi M; Ono M; Maeda M; Takada K; Hayashi T; Sato T; Miyanishi K; Takimoto R; Kobune M; Hirata K; Kato J Cancer Chemother Pharmacol; 2013 Mar; 71(3):789-97. PubMed ID: 23338051 [TBL] [Abstract][Full Text] [Related]
8. A phase II study of preoperative chemotherapy with docetaxel, cisplatin, and S-1 followed by gastrectomy with D2 plus para-aortic lymph node dissection for gastric cancer with extensive lymph node metastasis: JCOG1002. Ito S; Sano T; Mizusawa J; Takahari D; Katayama H; Katai H; Kawashima Y; Kinoshita T; Terashima M; Nashimoto A; Nakamori M; Onaya H; Sasako M Gastric Cancer; 2017 Mar; 20(2):322-331. PubMed ID: 27299887 [TBL] [Abstract][Full Text] [Related]
9. A randomized Phase II trial of systemic chemotherapy with and without trastuzumab followed by surgery in HER2-positive advanced gastric or esophagogastric junction adenocarcinoma with extensive lymph node metastasis: Japan Clinical Oncology Group study JCOG1301 (Trigger Study). Kataoka K; Tokunaga M; Mizusawa J; Machida N; Katayama H; Shitara K; Tomita T; Nakamura K; Boku N; Sano T; Terashima M; Sasako M; Jpn J Clin Oncol; 2015 Nov; 45(11):1082-6. PubMed ID: 26355164 [TBL] [Abstract][Full Text] [Related]
10. [Safety and efficacy of adjuvant chemotherapy with oxaliplatin and S-1 for patients with locally advanced gastric cancer after D2 lymph nodes dissection]. Bao YD; Zhang H; Dong L; Jiang KW; Ye YJ; Wang S; Zhou J Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):145-152. PubMed ID: 33508920 [No Abstract] [Full Text] [Related]
11. A phase II study of adjuvant S-1/cisplatin chemotherapy followed by S-1-based chemoradiotherapy for D2-resected gastric cancer. Shim HJ; Kim KR; Hwang JE; Bae WK; Ryu SY; Park YK; Nam TK; Chung IJ; Cho SH Cancer Chemother Pharmacol; 2016 Mar; 77(3):605-12. PubMed ID: 26846507 [TBL] [Abstract][Full Text] [Related]
12. Treatment of stage IV gastric cancer with induction chemotherapy using S-1 and cisplatin followed by curative resection in selected patients. Saito M; Kiyozaki H; Takata O; Suzuki K; Rikiyama T World J Surg Oncol; 2014 Dec; 12():406. PubMed ID: 25551581 [TBL] [Abstract][Full Text] [Related]
13. Phase II trial of neoadjuvant chemotherapy with intraperitoneal paclitaxel, S-1, and intravenous cisplatin and paclitaxel for stage IIIA or IIIB gastric cancer. Shinkai M; Imano M; Chiba Y; Iwama M; Shiraisi O; Yasuda A; Tsubaki M; Nishida S; Kimura Y; Yasuda T J Surg Oncol; 2019 Jan; 119(1):56-63. PubMed ID: 30444009 [TBL] [Abstract][Full Text] [Related]
14. [Neoadjuvant chemotherapy with combined S-1 plus weekly low-dose cisplatin followed by surgical resection for advanced gastric cancer]. Isobe T; Hashimoto K; Kizaki J; Miyagi M; Aoyagi K; Koufuji K; Shirouzu K Gan To Kagaku Ryoho; 2013 Oct; 40(10):1331-5. PubMed ID: 24105055 [TBL] [Abstract][Full Text] [Related]
15. Phase II trial of preoperative chemotherapy with docetaxel, cisplatin and S-1 for T4 locally advanced gastric cancer. Fushida S; Nashimoto A; Fukushima N; Kawachi Y; Fujimura T; Kuwabara S; Musha N; Jpn J Clin Oncol; 2012 Feb; 42(2):131-3. PubMed ID: 22167664 [TBL] [Abstract][Full Text] [Related]
16. Neoadjuvant chemotherapy with S-1 and CDDP in advanced gastric cancer. Kochi M; Fujii M; Kanamori N; Kaiga T; Takahashi T; Kobayashi M; Takayama T J Cancer Res Clin Oncol; 2006 Dec; 132(12):781-5. PubMed ID: 16804723 [TBL] [Abstract][Full Text] [Related]
17. Prognostic Role of Conversion Surgery for Unresectable Gastric Cancer. Fukuchi M; Ishiguro T; Ogata K; Suzuki O; Kumagai Y; Ishibashi K; Ishida H; Kuwano H; Mochiki E Ann Surg Oncol; 2015 Oct; 22(11):3618-24. PubMed ID: 25663597 [TBL] [Abstract][Full Text] [Related]
18. Survival results of a randomised two-by-two factorial phase II trial comparing neoadjuvant chemotherapy with two and four courses of S-1 plus cisplatin (SC) and paclitaxel plus cisplatin (PC) followed by D2 gastrectomy for resectable advanced gastric cancer. Yoshikawa T; Morita S; Tanabe K; Nishikawa K; Ito Y; Matsui T; Fujitani K; Kimura Y; Fujita J; Aoyama T; Hayashi T; Cho H; Tsuburaya A; Miyashita Y; Sakamoto J Eur J Cancer; 2016 Jul; 62():103-11. PubMed ID: 27244537 [TBL] [Abstract][Full Text] [Related]
19. Early results of a randomized two-by-two factorial phase II trial comparing neoadjuvant chemotherapy with two and four courses of cisplatin/S-1 and docetaxel/cisplatin/S-1 as neoadjuvant chemotherapy for locally advanced gastric cancer. Aoyama T; Nishikawa K; Fujitani K; Tanabe K; Ito S; Matsui T; Miki A; Nemoto H; Sakamaki K; Fukunaga T; Kimura Y; Hirabayashi N; Yoshikawa T Ann Oncol; 2017 Aug; 28(8):1876-1881. PubMed ID: 28486692 [TBL] [Abstract][Full Text] [Related]
20. Efficacy of conversion gastrectomy following docetaxel, cisplatin, and S-1 therapy in potentially resectable stage IV gastric cancer. Kinoshita J; Fushida S; Tsukada T; Oyama K; Okamoto K; Makino I; Nakamura K; Miyashita T; Tajima H; Takamura H; Ninomiya I; Ohta T Eur J Surg Oncol; 2015 Oct; 41(10):1354-60. PubMed ID: 26028256 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]